Socioeconomic Impact on Outcomes During the First Year of Life of Patients with Single Ventricle Heart Disease: An Analysis of the National Pediatric Cardiology Quality Improvement Collaborative Registry.
de Loizaga, SR; Schneider, K; Beck, AF; Zang, H; Ollberding, N; Tweddell, JS; Anderson, JB.
Pediatric Cardiology.
2022;
43:605-615.
Recent Advances in the Rheumatic Fever and Rheumatic Heart Disease Continuum.
Rwebembera, J; Nascimento, BR; Minja, NW; de Loizaga, S; Aliku, T; Dos Santos, LP A; Galdino, BF; Corte, LS; Silva, VR; Chang, AY; et al.
Pathogens.
2022;
11.
The Global Impact of Rheumatic Heart Disease.
Rwebembera, J; Beaton, AZ; de Loizaga, SR; Rocha, RT L; Doreen, N; Ssinabulya, I; Okello, E; Fraga, CL; Galdino, BF; Nunes, MC P; et al.
Current Cardiology Reports.
2021;
23.
Diagnosing rheumatic heart disease: where are we now and what are the challenges?.
de Loizaga, SR; Beaton, AZ; Nascimento, BR; Macedo, FV B; Spolaor, BC M; de Pádua, LB; Ribeiro, TF S; Oliveira, GC F; Oliveira, LR; de Almeida, LF R; et al.
Expert Review of Cardiovascular Therapy.
2021;
19:777-786.
Rheumatic Heart Disease in the United States: Forgotten But Not Gone: Results of a 10 Year Multicenter Review.
de Loizaga, SR; Arthur, L; Arya, B; Beckman, B; Belay, W; Brokamp, C; Choi, NH; Connolly, S; Dasgupta, S; Dibert, T; et al.
Journal of the American Heart Association.
2021;
10.
Inflammatory biomarkers in COVID-19-associated multisystem inflammatory syndrome in children, Kawasaki disease, and macrophage activation syndrome: a cohort study.
Rodriguez-Smith, JJ; Verweyen, EL; Clay, GM; Esteban, YM; de Loizaga, SR; Baker, EJ; Do, T; Dhakal, S; Lang, SM; Grom, AA; et al.
The Lancet. Rheumatology.
2021;
3:e574-e584.
Rheumatic Fever and Rheumatic Heart Disease in the United States.
de Loizaga, SR; Beaton, AZ.
Pediatric Annals.
2021;
50:e98-e104.